Fulgent Genetics, Inc. FLGT Gain/Loss on Asset Sales
Gain/Loss on Asset Sales at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnDispositionOfAssets.
The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Fulgent Genetics, Inc.'s gain/loss on asset sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Fulgent Genetics, Inc.'s gain/loss on asset sales?
- Fulgent Genetics, Inc. (FLGT) reported gain/loss on asset sales of $9K in Q1 2026.
- How has Fulgent Genetics, Inc.'s gain/loss on asset sales changed year-over-year?
- Fulgent Genetics, Inc.'s gain/loss on asset sales increased by 350.0% year-over-year, from $2K to $9K.
- What is the long-term trend for Fulgent Genetics, Inc.'s gain/loss on asset sales?
- Over 2 years (2021 to 2024), Fulgent Genetics, Inc.'s gain/loss on asset sales has grown at a -37.6% compound annual growth rate (CAGR), from -$850K to -$331K.
- What does gain/loss on asset sales mean?
- Gains or losses on asset disposals removed from operating cash flow — the cash impact is captured in investing activities.